Empirical Financial Services, LLC D.B.A. Empirical Wealth Management Bristol Myers Squibb CO Transaction History
Empirical Financial Services, LLC D.B.A. Empirical Wealth Management
- $4.37 Billion
- Q2 2025
A detailed history of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Empirical Financial Services, LLC D.B.A. Empirical Wealth Management holds 72,779 shares of BMY stock, worth $3.52 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
72,779
Previous 74,846
2.76%
Holding current value
$3.52 Million
Previous $4.56 Million
26.21%
% of portfolio
0.08%
Previous 0.12%
Shares
33 transactions
Others Institutions Holding BMY
# of Institutions
2,738Shares Held
1.59BCall Options Held
25.8MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.27 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.68 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.23 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.59 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.22 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $103B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...